SuperSTAT 2.0 Noninvasive Blood Pressure Algorithm Enhancement
NCT ID: NCT01482325
Last Updated: 2016-09-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
31 participants
INTERVENTIONAL
2011-11-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SuperSTAT Noninvasive Blood Pressure Monitor Evaluation
NCT00603486
Measurement of NonInvasive Blood Pressure in Neonates Through Adults and Special Populations
NCT02125331
Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support
NCT04577131
Hypotension Prediction Index (HPI) SMART-BP Trial
NCT05105477
Smartphone Blood Pressure Measurement to Screen for Hypertension
NCT06577688
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects requiring blood pressure monitoring
Any subject (neonate-adult) requiring hospital or clinic blood pressure monitoring
Blood pressure monitoring with GE Healthcare DASH2500 Patient Monitor
10-20 Non-Invasive Blood Pressure readings on investigational software in the DASH2500 Patient Monitor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood pressure monitoring with GE Healthcare DASH2500 Patient Monitor
10-20 Non-Invasive Blood Pressure readings on investigational software in the DASH2500 Patient Monitor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability of a minor subject ages 7 to 18 to provide written assent
* Ability to have multiple noninvasive blood pressures taken at one sitting
* Ability to apply three lead ECG, if needed for investigation
* Ability to detect the natural presence of an irregular pulse, for irregular pulse studies
Exclusion Criteria
* Any subject who cannot undergo 3-lead ECG, if needed
* Any subject deemed unstable by the principal investigator
* Any subject for whom precautions are necessary because of communicable disease
* Any subject that has a known disease or condition compromises musculoskeletal integrity
* Any subject that has a known disease or condition that contraindicates use of an NIBP cuff and ECG patches on the skin.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GE Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Josephs Hospital
Milwaukee, Wisconsin, United States
Wisconsin Heart Hospital
Wauwatosa, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
118.02-2011-GES-0002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.